About Trinity Biotech PLC
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: IE
- Website: https://www.trinitybiotech.com/
Frequently Asked Questions
What is the 52-week range for TRIB?
The 52-week high is $52.5 and the 52-week low is $5.01.
What is the P/E ratio for TRIB?
The P/E ratio data is currently unavailable.
What is the dividend yield for TRIB?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -166.14%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -72.78%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 5.27.
Analyst Recommendation Trends
Wall Street analyst consensus for TRIB over the last few months:
Latest TRIB News
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
European equities traded in the US as American depositary receipts were rising sharply late Thursday
Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players
The global point-of-care diagnostics market is projected to grow from USD 20.63 billion in 2026 to USD 31.46 billion by 2031, at an 8.8% CAGR. Growth is driven by demand for rapid, accurate and decentralized testing, alongside advances in molecular diagnostics, microfluidics, multiplex assays and portable analyzers. Biochemistry holds the largest technology share, while molecular diagnostics and infectious disease testing are set for strong growth. Clinical laboratories lead by end user, and Nor
Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center Infrastructure
Trinovium to supply RTI with advanced fluids and analytical systems for deployment in a U.S. commercial pilot focused on AI and high-performance computing data center infrastructure Data center power densities are increasing rapidly as AI workloads expand, creating greater thermal-management demands and interest in advanced liquid cooling solutions DUBLIN and WILSONVILLE, Ore., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company, today
Trinity Biotech's Liquid Cooling Unit Trinovium Enters Contract With Red Team Investments, Owner Of Modular Data Center Technology X-MDC
The contract establishes a framework for Trinovium and RTI to develop and deploy direct-to-chip liquid cooling solutions for artificial intelligence ("AI"), high-performance computing ("HPC") and modular